YOLFTbeta
KLEA HOLDING

KLEA HOLDING

ALKLH · PA · Healthcare / Diagnostics & Research

0.1806EUR+0.01 (+4.51%)

Price History

Full chart

Market Stats

Previous Close0.1728
Open0.174
Day Range0.1736 – 0.1812
52-Week Range0.1234 – 0.30
Volume623.39K
Market Cap42.35M
P/E (TTM)13.86
Forward P/E3.46
EPS0.01
Dividend Yield0.00%
Beta-0.52
50-Day Avg0.1501
200-Day Avg0.1848

About

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, and Saudi Arabia. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. In addition, the company engages in the production of pharmaceuticals. The company was formerly known as Visiomed Group SA and changed its name to Klea Holding SA in June 2024. Klea Holding SA was founded in 2007 and is headquartered in Paris, France.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Raphael Smila
  • Employees128
  • Headquarters34 Rue Laffitte, Paris, France, 75009, France
  • Websitehttps://www.kleaholding.com

Leadership

  • Mr. Raphael SmilaCEO & Director

Financials

Income Statement

Currency: EUR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.38M10.29M12.55M13.73M11.27M13.31M10.89M9.49M10.46M8.74M10.24M18.98M7.17M14.45M13.71M17.26M22.17M
Growth (%)-+134.68%+21.97%+9.43%-17.94%+18.09%-18.16%-12.86%+10.19%-16.45%+17.15%+85.37%-62.20%+101.38%-5.12%+25.93%+28.42%
Cost of Revenue3.33M7.52M8.88M10.80M9.02M10.75M13.42M16.29M16.22M16.20M18.13M22.74M7.89M11.24M7.41M9.01M12.38M
Gross Profit1.05M2.77M3.67M2.93M2.25M2.55M-2.53M-6.80M-5.77M-7.46M-7.89M-3.76M-715.00K3.20M6.30M8.25M9.79M
Gross Margin24.02%26.89%29.26%21.35%19.97%19.20%-23.18%-71.61%-55.13%-85.39%-77.12%-19.81%-9.97%22.16%45.95%47.82%44.17%
Operating Expense2.05M4.31M5.47M5.29M4.16M4.87M5.48M6.83M3.39M10.93M13.96M2.82M2.96M7.57M5.51M6.59M6.11M
Operating Income-1.00M-1.54M-1.80M-2.36M-1.91M-2.31M-8.00M-13.63M-9.15M-18.39M-21.85M-6.58M-3.68M-4.37M787.00K1.67M3.68M
Operating Margin-22.82%-14.98%-14.36%-17.20%-16.97%-17.39%-73.48%-143.61%-87.52%-210.51%-213.44%-34.68%-51.26%-30.24%5.74%9.65%16.59%
EBITDA-926.65K-1.02M-1.33M-1.82M-1.36M-1.37M-6.60M-12.73M-12.79M-19.19M-20.27M-4.53M-3.24M-2.21M5.85M2.66M5.31M
EBITDA Margin-21.14%-9.91%-10.56%-13.22%-12.04%-10.27%-60.62%-134.17%-122.33%-219.59%-197.98%-23.88%-45.14%-15.30%42.68%15.42%23.94%
Net Income-1.22M-2.07M-2.30M-2.81M-2.61M-2.60M-7.28M-13.41M-13.15M-19.79M-24.05M-5.15M-4.46M-5.28M902.00K1.41M2.28M
Net Income Margin-27.87%-20.10%-18.35%-20.43%-23.14%-19.52%-66.86%-141.32%-125.79%-226.45%-234.96%-27.14%-62.14%-36.53%6.58%8.14%10.29%
Interest Expense-97.30K65.05K46.78K155.55K95.31K351.73K28.62K-46.00K185.00K382.00K618.00K182.00K1.20M758.00K849.00K
Interest Expense % of Total Revenue-0.95%0.52%0.34%1.38%0.72%3.23%0.30%-0.53%1.81%2.01%8.62%1.26%8.78%4.39%3.83%

Balance Sheet

Currency: EUR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-13.11M15.43M12.91M12.62M15.01M19.27M19.41M20.14M18.52M14.73M5.91M44.07M36.09M36.60M37.83M37.28M
Total Liabilities-9.43M7.01M6.73M7.34M10.61M7.28M11.26M7.47M18.16M19.84M10.32M29.99M11.81M11.85M10.00M9.68M
Total Equity-3.68M8.42M6.19M5.27M4.40M11.99M8.15M12.66M361.00K-5.11M-4.41M14.07M24.27M24.10M27.95M27.61M
Cash-720.80K2.42M606.65K274.67K1.42M5.86M5.73M2.96M215.00K6.47M779.00K6.57M2.36M2.96M3.31M5.25M
Total Debt-1.73M2.10M803.82K1.53M1.12M10.00K3.48M62.17K2.77M3.03M15.00K4.95M5.62M7.93M5.88M5.37M
Net Debt-1.00M-318.54K197.18K1.26M-298.52K-5.85M-2.25M-2.90M2.55M-3.44M-764.00K-1.62M3.26M4.96M2.58M125.00K

Cash Flow

Currency: EUR2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.96M-4.22M-1.32M-2.35M217.56K-8.50M-11.79M-16.43M-12.27M-22.71M-10.90M-6.50M-1.74M1.11M932.00K4.93M
Investing Cash Flow-813.49K-339.68K-485.44K-343.34K-159.78K-992.50K-1.44M-832.63K-750.00K5.31M3.08M-15.02M-17.47M-1.56M-626.00K-440.00K
Financing Cash Flow-16.50K6.29M574.00K1.69M1.76M14.04M13.03M14.21M10.19M23.65M1.74M27.23M14.76M1.04M-199.00K-2.42M
Capital Expenditure678.96K326.51K541.68K343.79K302.25K713.30K941.26K671.73K774.00K56.00K245.00K196.00K5.51M2.61M766.00K1.03M
Free Cash Flow-2.64M-4.54M-1.86M-2.70M-84.69K-9.22M-12.73M-17.10M-13.05M-22.76M-11.14M-6.70M-7.26M-1.50M166.00K3.90M
FCF to OCF134.58%107.74%140.96%114.61%-38.93%108.39%107.99%104.09%106.31%100.25%102.25%103.01%416.77%-134.83%17.81%79.18%

Earnings

Report DateApr 29, 2016Oct 21, 2016May 5, 2017Oct 13, 2017Feb 28, 2018May 30, 2018Aug 29, 2018Nov 28, 2018Feb 27, 2019May 29, 2019Aug 28, 2019Nov 27, 2019Mar 31, 2020Oct 2, 2020Mar 31, 2021Oct 29, 2021Apr 1, 2022Oct 28, 2022Apr 26, 2023Oct 30, 2024Apr 25, 2025Sep 19, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual-0.29-0.48-0.51-0.40-0.300.00-0.270.00-0.130.00-0.030.00-1.14-0.01-0.25-0.10-0.01-0.01-0.010.000.000.00
Surprise----------------------
Timing----------------------

Key Statistics & Ratios

Market Cap42.35M
Enterprise Value43.10M
Trailing P/E13.86
Forward P/E3.46
Price / Sales1.91
Price / Book1.56
EPS0.01
Book Value0.09
Revenue (TTM)22.17M
Gross Profit (TTM)9.79M
EBITDA5.19M
Profit Margin10.29%
Operating Margin17.67%
Return on Equity8.23%
Return on Assets6.12%
Shares Outstanding305.55M
Shares Float186.62M
Beta-0.52
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 19, 20201:40